Taxorest®
The study of the function of external respiration showed that against the background of treatment
with TAXOREST®, the indices of bronchial patency improved (Table 1).
The influence of TAXOREST® on the indicators of external respiration in Table 1
patients with chronic bronchitis.
Indicator Before Treatment After Treatment with After Treatment with
Conventional Methods Taxorest®
Lung vital capacity 3654,1 ±231,9 3876,5±215,4 4220,7 ±243,1*
(VC), ml
Total lung capacity (TLC), ml 4730,2±276,5 5075,4±211,6 5246,1±223,6
Expiratory forced vital capacity of the lungs 2767,8±134,7 3225,6±148,2 3940,5±123,6*
(EFVCL), ml
* - p <0.05 compared to the indicator before treatment.
The results of the study of the function of external respiration indicate a sufficiently compensated
pathological process in the lungs, but, at the same time, there are phenomena of impaired bronchial
patency, mainly due to spasm of small bronchioles. The use of TAXOREST® had a positive impact on
the dynamics of the development of this process.
Thus, the results of this study indicate the therapeutic efficacy of TAXOREST® and the practicality of
its use in the complex treatment of chronic bronchitis, including the bronchitis of smokers.
In the process of using TAXOREST®, no side effects, complications, contraindications, or drug
dependence were identified.
TAXOREST® can be used for therapeutic and prophylactic purposes in the form of a biologically active
food supplement and in combination with any means of symptomatic and pathogenetic therapy used
to treat chronic bronchitis.
CONCLUSION
Biologically active food additive TAXOREST® has a normalizing effect on the functional activity of
the bronchial mucosa cells.
TAXOREST® is well tolerated when taken orally, has no side effects, and can be used as a therapeutic
and prophylactic biologically active food supplement.
REFERENCES
1. Belousov Y.B., Moiseev V.S., Lepakhin V.K. Clinical Pharmacology and Pharmacotherapy: A Guide
for Physicians. - M.: the Universe, 1993. -- 398 p.
2. Mashkovsky M.D., Medicines: Pharmacotherapy for doctors, manual: 2 parts. – Vilnius: ZAO “Gamta”,
1993.
3. Paleev N.R., Tsarkova L.N., Borokhov A.I. Chronic nonspecific lung diseases. - M.: Medicine, 1985.
-- 240 p.
4. Tsarkova L.N., Ilchenko V.A. Chronic nonspecific lung diseases / Diagnostics and treatment of internal
diseases: A guide for doctors. Ed. F.I. Komarova. - M.: Medicine, 1991. - T. 2. - S. 106-250.
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.